Compare LRMR & WNEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LRMR | WNEB |
|---|---|---|
| Founded | N/A | 1853 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 253.5M | 271.3M |
| IPO Year | 2014 | 2001 |
| Metric | LRMR | WNEB |
|---|---|---|
| Price | $3.10 | $13.12 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 11 | 3 |
| Target Price | $14.20 | ★ $15.00 |
| AVG Volume (30 Days) | ★ 1.3M | 29.9K |
| Earning Date | 11-16-2026 | 10-27-2026 |
| Dividend Yield | N/A | ★ 2.12% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.74 |
| Revenue | N/A | ★ $44,000.00 |
| Revenue This Year | N/A | $11.31 |
| Revenue Next Year | N/A | $8.11 |
| P/E Ratio | ★ N/A | $17.85 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.92 | $11.74 |
| 52 Week High | $6.42 | $15.01 |
| Indicator | LRMR | WNEB |
|---|---|---|
| Relative Strength Index (RSI) | 58.96 | 34.10 |
| Support Level | $2.89 | $12.90 |
| Resistance Level | $4.25 | $14.19 |
| Average True Range (ATR) | 0.30 | 0.31 |
| MACD | 0.09 | -0.07 |
| Stochastic Oscillator | 66.40 | 8.00 |
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell penetrating peptide technology platform. Its flagship product candidate, nomlabofusp, is a subcutaneously administered recombinant fusion protein designed to deliver frataxin (FXN) to the mitochondria of patients with Friedreich's ataxia (FA), a rare genetic disease characterized by insufficient production of FXN. The company also plans to use its intracellular delivery platform to design other fusion proteins to target additional rare diseases characterized by deficiencies in intracellular bioactive compounds.
Western New England Bancorp Inc through its bank subsidiary, provides a range of financial services to individuals and companies in western Massachusetts and northern Connecticut. These services include commercial lending, residential lending and consumer lending, checking, savings and time deposits, cash management, and wealth management. Substantially all of the company's revenues, profits, and assets are derived by the Bank from banking products and services.